# Preloading With Nicotine Replacement Therapy in HIV-positive Smokers to Improve Self-Efficacy and Quit Attempts

> **NCT04994444** · PHASE2,PHASE3 · COMPLETED · sponsor: **Brown University** · enrollment: 49 (actual)

## Conditions studied

- Tobacco Use Cessation

## Interventions

- **DRUG:** Nicoderm CQ 21Mg/24Hr Transdermal System

## Key facts

- **NCT ID:** NCT04994444
- **Lead sponsor:** Brown University
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-09-01
- **Primary completion:** 2024-04-30
- **Final completion:** 2024-04-30
- **Target enrollment:** 49 (ACTUAL)
- **Last updated:** 2025-04-06

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04994444

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04994444, "Preloading With Nicotine Replacement Therapy in HIV-positive Smokers to Improve Self-Efficacy and Quit Attempts". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04994444. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*